Last 7 days
0.1%
Last 30 days
0.2%
Last 90 days
17.5%
Trailing 12 Months
19.8%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-09-08 | Schenkein David P | acquired | - | - | 240 | - |
2023-09-08 | Guarini Kathryn | acquired | - | - | 240 | - |
2023-09-01 | McCourt Marion | sold | -208,638 | 834 | -250 | evp commercial |
2023-08-24 | Van Plew Daniel P | sold | -5,216,070 | 841 | -6,197 | evp & general mgr, industrial |
2023-08-23 | POON CHRISTINE A | acquired | 3,360,670 | 273 | 12,280 | - |
2023-08-23 | Fenimore Christopher R. | sold (taxes) | -4,380,150 | 842 | -5,198 | svp controller |
2023-08-23 | Van Plew Daniel P | acquired | 8,819,880 | 381 | 23,125 | evp & general mgr, industrial |
2023-08-23 | Landry Robert E | sold | -188,212 | 844 | -223 | evp finance cfo |
2023-08-23 | Van Plew Daniel P | sold (taxes) | -14,264,500 | 842 | -16,928 | evp & general mgr, industrial |
2023-08-23 | Fenimore Christopher R. | acquired | 2,797,620 | 399 | 7,000 | svp controller |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-26 | BROOKFIELD Corp /ON/ | added | 8.68 | -1,111,260 | 21,287,500 | 0.08% |
2023-09-21 | Baystate Wealth Management LLC | unchanged | - | -825 | 5,748 | -% |
2023-09-20 | BARCLAYS PLC | added | 58.25 | 55,605,000 | 200,462,000 | 0.13% |
2023-09-14 | IMS Capital Management | unchanged | - | -28,877 | 201,191 | 0.11% |
2023-09-12 | Farther Finance Advisors, LLC | added | 175 | 124,666 | 213,406 | 0.05% |
2023-09-05 | Delos Wealth Advisors, LLC | unchanged | - | -5,569 | 38,802 | 0.05% |
2023-09-01 | Portside Wealth Group, LLC | new | - | 285,979 | 285,979 | 0.05% |
2023-08-24 | Alberta Investment Management Corp | added | 131 | 2,638,100 | 5,211,570 | 0.05% |
2023-08-24 | Arlington Capital Management, Inc. | sold off | -100 | -227,603 | - | -% |
2023-08-23 | Rehmann Capital Advisory Group | added | 2.89 | -37,067 | 332,684 | 0.03% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 13, 2023 | capital world investors | 5.9% | 6,315,819 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 8.15% | 8,722,448 | SC 13G/A | |
Feb 03, 2023 | blackrock inc. | 8.6% | 9,166,817 | SC 13G/A | |
Jan 11, 2023 | jpmorgan chase & co | 5.6% | 6,101,044 | SC 13G | |
Feb 11, 2022 | capital world investors | 5.1% | 5,391,870 | SC 13G/A | |
Feb 10, 2022 | vanguard group inc | 7.72% | 8,158,515 | SC 13G/A | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 9.1% | 9,610,871 | SC 13G/A | |
Feb 16, 2021 | capital world investors | 6.7% | 7,017,122 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 27, 2023 | SC 13D/A | 13D - Major Acquisition | |
Sep 25, 2023 | SC TO-T/A | SC TO-T/A | |
Sep 12, 2023 | 3 | Insider Trading | |
Sep 12, 2023 | 3 | Insider Trading | |
Sep 12, 2023 | 4 | Insider Trading | |
Sep 12, 2023 | 4 | Insider Trading | |
Sep 12, 2023 | SC TO-T/A | SC TO-T/A | |
Sep 08, 2023 | 8-K/A | Current Report | |
Sep 08, 2023 | SC TO-T/A | SC TO-T/A | |
Sep 08, 2023 | 8-K | Current Report |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABBV | 270.6B | 56.0B | 3.87% | 9.15% | 31.15 | 4.83 | -2.31% | -31.27% |
BGNE | 264.5B | 1.8B | -4.90% | 38.70% | -152.67 | 146.06 | 69.45% | 14.65% |
VRTX | 90.1B | 9.5B | -0.55% | 22.80% | 26.79 | 9.48 | 13.83% | 5.33% |
REGN | 89.1B | 12.7B | 0.20% | 19.79% | 20.72 | 7.03 | -10.94% | -24.40% |
ALNY | 22.1B | 1.2B | -7.72% | -12.71% | -20.77 | 17.85 | 39.94% | -8.44% |
SRPT | 11.5B | 1.0B | 4.08% | 13.95% | -12.68 | 11.47 | 20.15% | -79.16% |
UTHR | 10.9B | 2.1B | 2.86% | 12.91% | 12.51 | 5.17 | 18.01% | 38.16% |
MID-CAP | ||||||||
BPMC | 3.0B | 225.6M | 1.84% | -24.74% | -5.46 | 13.42 | -2.11% | 21.02% |
MDGL | 2.8B | - | -16.23% | 132.76% | -8.48 | - | - | -28.88% |
RARE | 2.6B | 402.9M | 0.63% | -8.39% | -3.66 | 6.55 | 20.50% | -42.46% |
MRTX | 2.4B | 27.2M | 10.98% | -38.97% | -3.26 | 88.36 | - | -14.43% |
SMALL-CAP | ||||||||
CYTK | 3.1B | - | -16.61% | -39.22% | -7.31 | 33.28 | 34.30% | -149.91% |
CPRX | 1.3B | 302.9M | -14.36% | -1.93% | 11.22 | 4.28 | 77.72% | 112.02% |
MGNX | 291.7M | 152.5M | -6.92% | 34.57% | 39.16 | 1.91 | 127.84% | 103.41% |
CRBP | 28.1M | - | -6.20% | 3967.91% | -0.61 | - | - | -31.51% |
10.5%
10.3%
15.6%
13.2%
61.5%
25.4%
0%
Y-axis is the maximum loss one would have experienced if Regeneron Pharmaceuticals was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 2.4% | 12,671 | 12,370 | 12,173 | 13,710 | 14,227 | 16,508 | 16,072 | 13,543 | 12,384 | 9,198 | 8,497 | 7,938 | 7,387 | 7,013 | 6,558 | 6,622 | 6,542 | 6,572 | 6,711 | 6,365 | 6,203 |
Costs and Expenses | 5.0% | 8,337 | 7,943 | 7,434 | 7,478 | 7,372 | 7,416 | 7,125 | 6,069 | 5,704 | 5,208 | 4,921 | 4,852 | 4,617 | 4,583 | 4,348 | 4,370 | 4,401 | 4,125 | 4,176 | 4,010 | 3,914 |
S&GA Expenses | 7.8% | 2,443 | 2,267 | 2,116 | 2,015 | 1,931 | 1,869 | 1,825 | 1,569 | 1,451 | 1,384 | 1,346 | 1,494 | 1,472 | 1,418 | 1,342 | 952 | 1,017 | 1,087 | 1,127 | 1,475 | 1,412 |
R&D Expenses | 7.6% | 4,141 | 3,850 | 3,593 | 3,287 | 3,041 | 2,961 | 2,860 | 2,779 | 2,798 | 2,806 | 2,647 | 2,543 | 2,384 | 2,548 | 2,450 | 1,782 | 1,813 | 1,456 | 1,469 | 2,113 | 2,086 |
EBITDA | -100.0% | - | 5,086 | 5,260 | 6,409 | 6,696 | 9,483 | 9,669 | 8,378 | 7,558 | 4,707 | 4,103 | 3,753 | 3,498 | 2,796 | 2,670 | 2,445 | 2,295 | 2,707 | 2,730 | 2,599 | 2,530 |
EBITDA Margin | -100.0% | - | 0.41* | 0.43* | 0.47* | 0.45* | 0.57* | 0.60* | 0.62* | 0.61* | 0.51* | 0.48* | 0.47* | 0.47* | 0.38* | 0.37* | 0.33* | 0.32* | 0.39* | 0.41* | 0.41* | 0.41* |
Interest Expenses | 9.1% | 70.00 | 64.00 | 59.00 | 56.00 | 55.00 | 56.00 | 57.00 | 58.00 | 70.00 | 65.00 | 57.00 | 49.00 | 30.00 | 29.00 | 30.00 | 31.00 | 31.00 | 29.00 | 28.00 | 27.00 | 25.00 |
Earnings Before Taxes | 2.6% | 4,775 | 4,656 | 4,859 | 6,038 | 6,344 | 9,134 | 9,326 | 8,047 | 7,229 | 4,395 | 3,810 | 3,476 | 3,246 | 2,552 | 2,429 | 2,216 | 2,083 | 2,514 | 2,554 | 2,432 | 2,362 |
EBT Margin | -100.0% | - | 0.38* | 0.40* | 0.44* | 0.42* | 0.55* | 0.58* | 0.59* | 0.58* | 0.48* | 0.45* | 0.44* | 0.44* | 0.35* | 0.33* | 0.30* | 0.29* | 0.36* | 0.38* | 0.38* | 0.38* |
Net Income | 2.8% | 4,299 | 4,183 | 4,338 | 5,370 | 5,687 | 7,934 | 8,075 | 6,996 | 6,205 | 4,004 | 3,513 | 3,156 | 2,984 | 2,279 | 2,116 | 2,144 | 2,069 | 2,428 | 2,445 | 1,798 | 1,591 |
Net Income Margin | -100.0% | - | 0.34* | 0.36* | 0.39* | 0.38* | 0.48* | 0.50* | 0.52* | 0.50* | 0.44* | 0.41* | 0.40* | 0.40* | 0.31* | 0.29* | 0.29* | 0.29* | 0.35* | 0.36* | 0.28* | 0.26* |
Free Cashflow | -100.0% | - | 4,281 | 5,015 | 5,668 | 8,452 | 8,515 | 7,081 | 5,940 | 2,272 | 2,589 | 2,618 | 2,175 | 2,986 | 2,231 | 2,430 | 2,371 | 2,267 | 2,473 | 2,195 | 2,033 | 1,995 |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | 2.0% | 30,658 | 30,060 | 29,215 | 27,678 | 27,206 | 26,349 | 25,435 | 23,672 | 21,486 | 17,772 | 17,163 | 16,084 | 14,429 | 15,758 | 14,805 | 13,939 | 13,174 | 12,855 | 11,735 | 10,806 | 9,952 |
Current Assets | 0.1% | 16,923 | 16,909 | 15,884 | 15,429 | 15,530 | 14,306 | 14,015 | 13,775 | 13,338 | 10,055 | 9,779 | 9,098 | 7,860 | 8,644 | 7,689 | 7,109 | 6,651 | 6,929 | 6,448 | 5,720 | 4,815 |
Cash Equivalents | -50.5% | 1,937 | 3,916 | 3,106 | 3,491 | 3,395 | 3,346 | 2,898 | 3,432 | 2,072 | 1,438 | 2,194 | 1,573 | 1,992 | 2,208 | 1,630 | 1,385 | 1,046 | 1,709 | 1,480 | 1,088 | 918 |
Inventory | 3.4% | 2,508 | 2,425 | 2,402 | 2,412 | 2,219 | 1,992 | 1,951 | 2,054 | 1,984 | 2,165 | 1,917 | 1,802 | 1,641 | 1,481 | 1,416 | 1,344 | 1,317 | 1,209 | 1,151 | 1,040 | 929 |
Net PPE | - | - | - | - | 3,704 | 3,638 | 3,556 | 3,482 | 3,396 | 3,359 | 3,263 | 3,222 | 3,138 | 3,031 | 2,945 | 2,890 | 2,771 | 2,677 | 2,613 | 2,576 | 2,524 | 2,462 |
Liabilities | 1.1% | 6,640 | 6,565 | 6,551 | 6,239 | 6,518 | 6,434 | 6,666 | 6,414 | 6,359 | 5,795 | 6,138 | 5,959 | 5,371 | 3,625 | 3,716 | 3,435 | 3,418 | 3,410 | 2,977 | 2,937 | 2,766 |
Current Liabilities | 0.1% | 3,104 | 3,100 | 3,141 | 2,879 | 3,034 | 3,008 | 3,933 | 3,715 | 3,732 | 3,218 | 2,697 | 2,338 | 3,702 | 2,055 | 2,097 | 1,765 | 1,713 | 1,511 | 1,443 | 1,417 | 1,331 |
LT Debt, Non Current | 0.0% | 1,982 | 1,982 | 1,981 | 1,981 | 1,981 | 1,980 | 1,980 | 1,980 | 1,979 | 1,979 | 1,979 | 1,978 | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | 2.2% | 24,018 | 23,495 | 22,664 | 21,439 | 20,688 | 19,915 | 18,769 | 17,258 | 15,127 | 11,977 | 11,025 | 10,126 | 9,057 | 12,133 | 11,090 | 10,504 | 9,756 | 9,445 | 8,757 | 7,868 | 7,186 |
Retained Earnings | 4.0% | 25,093 | 24,125 | 23,307 | 22,110 | 20,794 | 19,942 | 18,968 | 16,739 | 15,107 | 12,008 | 10,893 | 9,744 | 8,902 | 8,004 | 7,380 | 6,588 | 5,918 | 5,725 | 5,254 | 4,434 | 3,839 |
Additional Paid-In Capital | 2.7% | 10,889 | 10,598 | 9,949 | 9,518 | 9,120 | 8,754 | 8,088 | 7,919 | 7,226 | 6,888 | 6,716 | 6,593 | 6,263 | 5,211 | 4,429 | 4,388 | 4,264 | 4,161 | 3,912 | 3,841 | 3,713 |
Shares Outstanding | -0.1% | 107 | 107 | - | 107 | 108 | 107 | - | 106 | 105 | 105 | - | 106 | 110 | 110 | - | 109 | 109 | 109 | - | 108 | 108 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 10.7% | 4,739 | 4,281 | 5,015 | 5,668 | 8,452 | 8,515 | 7,081 | 5,940 | 2,272 | 2,589 | 2,618 | 2,175 | 2,986 | 2,231 | 2,430 | 2,371 | 2,267 | 2,473 | 2,195 | 2,033 | 1,995 |
Share Based Compensation | 5.3% | 839 | 797 | 725 | 681 | 652 | 638 | 602 | 535 | 499 | 457 | 432 | 444 | 460 | 462 | 464 | 458 | 452 | 453 | 427 | 428 | 441 |
Cashflow From Investing | -85.2% | -4,288 | -2,315 | -3,784 | -3,939 | -6,570 | -6,031 | -5,384 | -3,677 | -2,014 | -686 | -70.60 | 26.00 | 595 | -1,694 | -2,027 | -2,085 | -2,164 | -1,813 | -1,463 | -1,532 | -1,605 |
Cashflow From Financing | -36.7% | -1,909 | -1,396 | -1,009 | -1,668 | -557 | -574 | -1,005 | -404 | -177 | -2,672 | -1,970 | -2,010 | -2,633 | -36.40 | -252 | 11.00 | 25.00 | 29.00 | -77.10 | -204 | -216 |
Buy Backs | 13.5% | 2,761 | 2,432 | 2,083 | 2,526 | 1,803 | 1,698 | 1,645 | 1,184 | 1,094 | 5,877 | 5,847 | 5,755 | 5,674 | 602 | 276 | 29.00 | 14.00 | 14.00 | 4.00 | 4.00 | - |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenues: | ||||
Revenues | $ 3,158.1 | $ 2,857.2 | $ 6,320.2 | $ 5,822.3 |
Expenses: | ||||
Research and development | 1,085.3 | 794.3 | 2,186.5 | 1,638.1 |
Acquired in-process research and development | 0.0 | 197.0 | 56.1 | 225.1 |
Selling, general, and administrative | 652.0 | 476.3 | 1,253.1 | 926.3 |
Other operating (income) expense, net | (0.6) | (17.4) | (1.1) | (37.6) |
Total Expenses | 2,141.6 | 1,747.3 | 4,357.0 | 3,453.9 |
Income from operations | 1,016.5 | 1,109.9 | 1,963.2 | 2,368.4 |
Other income (expense): | ||||
Other income (expense), net | 85.3 | (133.6) | 14.6 | (317.4) |
Interest expense | (18.9) | (13.1) | (36.9) | (26.7) |
Total other income (expense) | 66.4 | (146.7) | (22.3) | (344.1) |
Income before income taxes | 1,082.9 | 963.2 | 1,940.9 | 2,024.3 |
Income tax expense | 114.5 | 111.1 | 154.7 | 198.7 |
Net income | $ 968.4 | $ 852.1 | $ 1,786.2 | $ 1,825.6 |
Net income per share - basic (in dollars per share) | $ 9.05 | $ 7.90 | $ 16.69 | $ 17.01 |
Net income per share - diluted (in dollars per share) | $ 8.50 | $ 7.47 | $ 15.68 | $ 16.07 |
Weighted average shares outstanding - basic (in shares) | 107.0 | 107.9 | 107.0 | 107.3 |
Weighted average shares outstanding - diluted (in shares) | 113.9 | 114.0 | 113.9 | 113.6 |
Statements of Comprehensive Income | ||||
Net income | $ 968.4 | $ 852.1 | $ 1,786.2 | $ 1,825.6 |
Other comprehensive income (loss), net of tax: | ||||
Unrealized (loss) gain on debt securities | (15.7) | (53.7) | 41.5 | (198.6) |
Loss on foreign currency translation | (0.4) | 0.0 | (0.4) | 0.0 |
Unrealized gain on cash flow hedges | 0.0 | 0.0 | 0.0 | 1.0 |
Comprehensive income | 952.3 | 798.4 | 1,827.3 | 1,628.0 |
Net product sales | ||||
Revenues: | ||||
Revenues | 1,772.1 | 1,754.4 | 3,440.1 | 3,393.0 |
Expenses: | ||||
Cost of goods, collaboration and contract manufacturing | 192.4 | 149.2 | 400.8 | 356.5 |
Collaboration revenue | ||||
Revenues: | ||||
Revenues | 1,316.7 | 1,043.6 | 2,694.8 | 2,276.1 |
Other revenue | ||||
Revenues: | ||||
Revenues | 69.3 | 59.2 | 185.3 | 153.2 |
Cost of collaboration and contract manufacturing | ||||
Expenses: | ||||
Cost of goods, collaboration and contract manufacturing | $ 212.5 | $ 147.9 | $ 461.6 | $ 345.5 |
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 1,937.2 | $ 3,105.9 |
Marketable securities | 6,990.5 | 4,636.4 |
Accounts receivable, net | 5,121.3 | 5,328.7 |
Inventories | 2,507.7 | 2,401.9 |
Prepaid expenses and other current assets | 366.3 | 411.2 |
Total current assets | 16,923.0 | 15,884.1 |
Marketable securities | 6,327.2 | 6,591.8 |
Property, plant, and equipment, net | 3,922.6 | 3,763.0 |
Intangible assets, net | 953.0 | 915.5 |
Deferred tax assets | 2,138.5 | 1,723.7 |
Other noncurrent assets | 393.2 | 336.4 |
Total assets | 30,657.5 | 29,214.5 |
Current liabilities: | ||
Accounts payable | 547.3 | 589.2 |
Accrued expenses and other current liabilities | 2,176.0 | 2,074.2 |
Deferred revenue | 381.1 | 477.9 |
Total current liabilities | 3,104.4 | 3,141.3 |
Long-term debt | 1,982.2 | 1,981.4 |
Finance lease liabilities | 720.0 | 720.0 |
Deferred revenue | 116.2 | 69.8 |
Other noncurrent liabilities | 716.8 | 638.0 |
Total liabilities | 6,639.6 | 6,550.5 |
Stockholders' equity: | ||
Preferred Stock, par value $.01 per share; 30.0 shares authorized; issued and outstanding - none | 0.0 | 0.0 |
Additional paid-in capital | 10,888.5 | 9,949.3 |
Retained earnings | 25,092.9 | 23,306.7 |
Accumulated other comprehensive loss | (197.7) | (238.8) |
Treasury Stock, at cost; 24.5 shares in 2023 and 22.6 shares in 2022 | (11,765.9) | (10,353.3) |
Total stockholders' equity | 24,017.9 | 22,664.0 |
Total liabilities and stockholders' equity | 30,657.5 | 29,214.5 |
Class A Stock | ||
Stockholders' equity: | ||
Common stock | 0.0 | 0.0 |
Common Stock | ||
Stockholders' equity: | ||
Common stock | $ 0.1 | $ 0.1 |